Home Cart Sign in  
Chemical Structure| 717906-29-1 Chemical Structure| 717906-29-1

Structure of PF-431396
CAS No.: 717906-29-1

Chemical Structure| 717906-29-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PF-431396 is dual focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (PYK2) inhibitor (IC50 values are 2 and 11 nM respectively), PF-431396 has a Kd value of 445 nM for BRD4.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PF-431396

CAS No. :717906-29-1
Formula : C22H21F3N6O3S
M.W : 506.50
SMILES Code : CS(=O)(N(C)C1=CC=CC=C1CNC2=NC(NC3=CC4=C(C=C3)NC(C4)=O)=NC=C2C(F)(F)F)=O
MDL No. :MFCD16038300
InChI Key :POJZIZBONPAWIV-UHFFFAOYSA-N
Pubchem ID :11598628

Safety of PF-431396

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of PF-431396

RTK
cytoskeleton

Isoform Comparison

Biological Activity

Target
  • FAK

    FAK, IC50:2 nM

    PYK2, IC50:11 nM

In Vitro:

Cell Line
Concentration Treated Time Description References
human pulmonary alveolar epithelial cells (HPAEpiCs) 0.1, 1, 3 µM 1 hour inhibited SiNP-induced COX-2 expression PMC10604097
A20 cells 2.5 µM 1, 2, or 4 hours PF-431396 treatment significantly reduced the ability of A20 cells to spread on fibronectin, indicating that the kinase activities of Pyk2 and FAK are crucial for B cell spreading. PMC2755694
MV4-11 cells 300 nM 16 hours To assess the effect of PF-431396 on the translation rate of proteins in MV4-11 cells, it was found that PF-431396 treatment significantly affected the translation of proteins involved in cell cycle regulation and extracellular matrix organization. PMC9522596
gastric fundus smooth muscle cells 0.3 μM 2 minutes PDBu or calyculin A contracted gastric fundus smooth muscle strips and increased FAK Y397 phosphorylation in a Ca2+-independent manner PMC5983118
MV4-11 cells 200 nM 24 hours To assess the effect of PF-431396 on the adhesion of MV4-11 cells, it was found that PF-431396 treatment significantly reduced cell adhesion. PMC9522596
A375 melanoma cells 1 µM 24 hours To investigate the effect of PF-431396 on melanoma cell migration and matrix degradation. Results showed that PF-431396 significantly inhibited melanoma cell migration without altering matrix degradation. PMC10006204
MG6 cells 1000 nM 24 hours To assess the effect of Pyk2 inhibition on MG6 cell proliferation, results showed a significant decrease in proliferation at 1000 nM concentration. PMC11301859
HMC3 cells 1000 nM 24 hours To assess the effect of Pyk2 inhibition on HMC3 cell multinucleation, results showed a significant increase in multinucleation at 1000 nM concentration. PMC11301859
Caco-2 cells 0.25 μM 24 hours Treatment with PF-43 increased the epithelial barrier function and enhanced mitochondrial respiration levels in Caco-2 cells PMC8078543
H2596 cells 1 µM 48 hours Induced apoptosis, a two-fold increase in the number of apoptotic cells in H2596 cell line PMC5902231
MiaPaca 2 cells 1 µM 48 hours Induced apoptosis, significant increase in the number of apoptotic cells in MiaPaca 2 cells PMC5902231
Capan 1 cells 2 µM and 4 µM 48 hours Induced apoptosis, significant increase in the number of apoptotic cells in Capan 1 cells PMC5902231
gastric fundus smooth muscle cells 0.3 μM 5 seconds inhibited EFS-induced gastric fundus smooth muscle contractions and FAK Y397 phosphorylation PMC5983118

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats De-endothelialized caudal arterial smooth muscle strips In vitro administration 10 µM 30 minutes PF-431396 inhibited both phasic and tonic components of the K+-induced contractile response and Pyk2 autophosphorylation, indicating that Pyk2 plays an important role in K+-induced contraction. PMC4423659

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.97mL

0.39mL

0.20mL

9.87mL

1.97mL

0.99mL

19.74mL

3.95mL

1.97mL

 

Historical Records

Categories